Molecular Characterization and Antimicrobial Susceptibilities of Nocardia Species Isolated from the Soil; a Comparison with Species Isolated from Humans
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Novel Bioactive Metabolites from a Marine Derived Bacterium Nocardia Sp. ALAA 2000 Mervat M
J. Antibiot. 61(6): 379–386, 2008 THE JOURNAL OF ORIGINAL ARTICLE ANTIBIOTICS Novel Bioactive Metabolites from a Marine Derived Bacterium Nocardia sp. ALAA 2000 Mervat M. A. El-Gendy, Usama W. Hawas, Marcel Jaspars Received: November 4, 2007 / Accepted: June 10, 2008 © Japan Antibiotics Research Association Abstract Extracts of the Egyptian marine actinomycete, represent an enormous resource for the discovery of Nocardia sp. ALAA 2000, were found to be highly chemotherapeutic agents. Given the diversity of marine bioactive. It was isolated from the marine red alga organisms and habitats, marine natural products encompass Laurenica spectabilis collected off the Ras-Gharib coast of a wide variety of chemical classes such as terpenes, the Red Sea, Egypt. According to detailed identification polyketides, acetogenins, peptides and alkaloids of varying studies, the strain was classified as a member of the genus structures, representing biosynthetic schemes of stunning Nocardia. The cultivation and chemical analysis of this variety. Over the past 30 to 40 years, marine organisms species yielded four structurally related compounds have been the focus of a worldwide effort for the discovery namely, chrysophanol 8-methyl ether (1), asphodelin; 4,7Ј- of novel natural products [1]. Marine microorganisms bichrysophanol (2) and justicidin B (3), in addition to (actinobacteria) are sources of novel compounds with often a novel bioactive compound ayamycin; 1,1-dichloro-4- unique structures and potential therapeutic applications. ethyl-5-(4-nitro-phenyl)-hexan-2-one (4) which is unique The Actinomycetes are widely distributed in natural and in contain both chlorination and a rarely observed nitro manmade environments and are also well known as a rich group. -
Twenty Years of Passive Disease Surveillance of Roe Deer (Capreolus Capreolus) in Slovenia
animals Article Twenty Years of Passive Disease Surveillance of Roe Deer (Capreolus capreolus) in Slovenia Diana Žele Vengušt 1, Urška Kuhar 2, Klemen Jerina 3 and Gorazd Vengušt 1,* 1 Institute of Pathology, Wild Animals, Fish and Bees, Veterinary Faculty, University of Ljubljana, Gerbiˇceva60, 1000 Ljubljana, Slovenia; [email protected] 2 Institute of Microbiology and Parasitology, Veterinary Faculty, University of Ljubljana, Gerbiˇceva60, 1000 Ljubljana, Slovenia; [email protected] 3 Department of Forestry and Renewable Forest Resources, Biotechnical Faculty, Veˇcnapot 83, 1000 Ljubljana, Slovenia; [email protected] * Correspondence: [email protected]; Tel.: +386-(1)-4779-196 Simple Summary: Wildlife can serve as a reservoir for highly contagious and deadly diseases, many of which are infectious to domestic animals and/or humans. Wildlife disease surveillance can be considered an essential tool to provide important information on the health status of the population and for the protection of human health. Between 2000 and 2019, examinations of 510 roe deer carcasses were conducted by comprehensive necropsy and other laboratory tests. In conclusion, the results of this research indicate a broad spectrum of roe deer diseases, but no identified disease can be considered a significant health threat to other wildlife species and/or to humans. Abstract: In this paper, we provide an overview of the causes of death of roe deer (Capreolus capreolus) diagnosed within the national passive health surveillance of roe deer in Slovenia. From 2000 to 2019, postmortem examinations of 510 free-ranging roe deer provided by hunters were conducted at the Veterinary Faculty, Slovenia. -
Evaluation Ofapi Coryne System for Identifying Coryneform Bacteria
756 Y Clin Pathol 1994;47:756-759 Evaluation of API Coryne system for identifying coryneform bacteria J Clin Pathol: first published as 10.1136/jcp.47.8.756 on 1 August 1994. Downloaded from A Soto, J Zapardiel, F Soriano Abstract that are aerobe or facultatively aerobe, non- Aim-To identify rapidly and accurately spore forming organisms of the following gen- coryneform bacteria, using a commercial era: Corynebacterium, Listeria, Actinomyces, strip system. Arcanobacterium, Erysipelothrix, Oerskovia, Methods-Ninety eight strains of Cory- Brevibacterium and Rhodococcus. It also per- nebacterium species and 62 additional mits the identification of Gardnerella vaginalis strains belonging to genera Erysipelorix, which often has a diphtheroid appearance and Oerskovia, Rhodococcus, Actinomyces, a variable Gram stain. Archanobacterium, Gardnerella and We studied 160 organisms in total from dif- Listeria were studied. Bacteria were ferent species of the Corynebacterium genus, as identified using conventional biochemi- well as from other morphological related gen- cal tests and a commercial system (API- era or groups, some of them not included in Coryne, BioMerieux, France). Fresh rab- the API Coryne database. bit serum was added to fermentation tubes for Gardnerella vaginalis isolates. Results-One hundred and five out ofthe Methods 160 (65.7%) organisms studied were cor- The study was carried out on Gram positive rectly and completely identified by the bacilli belonging to the genera Coryne- API Coryne system. Thirty five (21.8%) bacterium, Erysipelothrix, Oerskovia, Rhodococcus, more were correctly identified with addi- Actinomyces, Arcanobacterium, Gardnerella and tional tests. Seventeen (10-6%) organisms Listeria included in the API Coryne database were not identified by the system and (table 1). -
Skin Infections Caused by Nocardia Species. a Case Report and Review of the Literature of Primary
REVIEW ARTICLE Skin Infections Caused by Nocardia Species A Case Report and Review of the Literature of Primary Cutaneous Nocardiosis Reported in the United States Mihaela Parvu, MD,* Gary Schleiter, MD,Þþ and John G. Stratidis, MDÞþ oxide. He thought he may have had a splinter there, so he punc- Abstract: Nocardiosis is an uncommon infection caused by Nocardia tured the lesions with a needle to remove it. Later, erythema and species, a group of aerobic actinomycetes. Disease in humans is rare swelling appeared in the region surrounding the 2 spots. On and often affects patients with underlying immune compromise. Acqui- November 21, 2008, he presented to our emergency department sition of this organism is usually via the respiratory tract, but direct in- complaining of pain, redness, and swelling of the left arm. A cul- oculation into the skin is possible, usually in the setting of trauma. We ture from one of his abscesses was sent for analysis. The patient report an encounter of a previously healthy man, with cellulitis and abscess was then discharged home with a prescription of trimethoprim- formation of the upper arm. The organism isolated from the wound culture sulfamethoxazole (Bactrim) (TMP-SMX) for a suspected staph- was a partially acid-fast, Gram-positive rod, identified as Nocardia spe- ylococcal skin infection. However, increased pain in his left arm cies. Our patient recovered after 6 months of treatment with trimethoprim- and the presence of chills prompted him to return to the emer- sulfamethoxazole. Along with our case, we reviewed the profile of patients gency department 2 days later. -
Cord Factor (A,A-Trehalose 6,6'-Dimycolate) Inhibits Fusion Between Phospholipid Vesicles (Trehalose/Membrane Fusion/Liposomes/Tuberculosis/Nocardiosis) B
Proc. Nati. Acad. Sci. USA Vol. 88, pp. 737-740, February 1991 Biochemistry Cord factor (a,a-trehalose 6,6'-dimycolate) inhibits fusion between phospholipid vesicles (trehalose/membrane fusion/liposomes/tuberculosis/nocardiosis) B. J. SPARGO*t, L. M. CROWE*, T. IONEDAf, B. L. BEAMAN§, AND J. H. CROWE* *Department of Zoology and §Department of Medical Microbiology and Immunology, University of California, Davis, CA 95616; and tUniversidade de Sio Paulo, Instituto de Quimica, 05508 Sao Paulo, S.P., Brazil Communicated by John D. Baldeschwieler, October 15, 1990 ABSTRACT The persistence of numerous pathogenic bac- antitumor activity (11), immunomodulation (12, 13), and teria important in disease states, such as tuberculosis, in granulomagenic activity (14). Indirect evidence has been humans and domestic animals has been ascribed to an inhibi- provided that CF might be responsible for inhibiting fusion tion of fusion between the phagosomal vesicles containing the between adjacent membranes in vivo (6). This finding is bacteria and lysosomes in the host cells [Elsbach, P. & Weiss, particularly appealing in view of the work of Goodrich and J. (1988) Biochim. Biophys. Adia 974, 29-52; Thoen, C. 0. Baldeschwieler (15, 16) and Hoekstra and coworkers (17, 18), (1988)J. Am. Vet. Med. Assoc. 193, 1045-1048]. In tuberculosis where carbohydrates anchored to the membrane by a hydro- this effect has been indirectly attributed to the production of phobic group have been shown to confer an inhibition of cord factor (a,a-trehalose 6,6'-dimycolate). We show here that fusion in model membrane systems. Goodrich and Balde- cord factor is extraordinarily effective at inhibiting Ca2+- schwieler (15, 16) reported that galactose anchored to cho- induced fusion between phospholipid vesicles and suggest a lesterol prevents fusion damage to liposomes during freezing mechanism by which cord factor confers this effect. -
Biotechnological and Ecological Potential of Micromonospora Provocatoris Sp
marine drugs Article Biotechnological and Ecological Potential of Micromonospora provocatoris sp. nov., a Gifted Strain Isolated from the Challenger Deep of the Mariana Trench Wael M. Abdel-Mageed 1,2 , Lamya H. Al-Wahaibi 3, Burhan Lehri 4 , Muneera S. M. Al-Saleem 3, Michael Goodfellow 5, Ali B. Kusuma 5,6 , Imen Nouioui 5,7, Hariadi Soleh 5, Wasu Pathom-Aree 5, Marcel Jaspars 8 and Andrey V. Karlyshev 4,* 1 Department of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia; [email protected] 2 Department of Pharmacognosy, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt 3 Department of Chemistry, Science College, Princess Nourah Bint Abdulrahman University, Riyadh 11671, Saudi Arabia; [email protected] (L.H.A.-W.); [email protected] (M.S.M.A.-S.) 4 School of Life Sciences Pharmacy and Chemistry, Faculty of Science, Engineering and Computing, Kingston University London, Penrhyn Road, Kingston upon Thames KT1 2EE, UK; [email protected] 5 School of Natural and Environmental Sciences, Newcastle University, Newcastle upon Tyne NE1 7RU, UK; [email protected] (M.G.); [email protected] (A.B.K.); [email protected] (I.N.); [email protected] (H.S.); [email protected] (W.P.-A.) 6 Indonesian Centre for Extremophile Bioresources and Biotechnology (ICEBB), Faculty of Biotechnology, Citation: Abdel-Mageed, W.M.; Sumbawa University of Technology, Sumbawa Besar 84371, Indonesia 7 Leibniz-Institut DSMZ—German Collection of Microorganisms and Cell Cultures, Inhoffenstraße 7B, Al-Wahaibi, L.H.; Lehri, B.; 38124 Braunschweig, Germany Al-Saleem, M.S.M.; Goodfellow, M.; 8 Marine Biodiscovery Centre, Department of Chemistry, University of Aberdeen, Old Aberdeen AB24 3UE, Kusuma, A.B.; Nouioui, I.; Soleh, H.; UK; [email protected] Pathom-Aree, W.; Jaspars, M.; et al. -
The Missing Piece of the Type II Fatty Acid Synthase System from Mycobacterium Tuberculosis
The missing piece of the type II fatty acid synthase system from Mycobacterium tuberculosis Emmanuelle Sacco*, Adrian Suarez Covarrubias†, Helen M. O’Hare‡, Paul Carroll§, Nathalie Eynard*, T. Alwyn Jones†, Tanya Parish§, Mamadou Daffe´ *, Kristina Ba¨ ckbro†, and Annaı¨kQue´ mard*¶ *De´partement des Me´canismes Mole´culaires des Infections Mycobacte´riennes, Institut de Pharmacologie et de Biologie Structurale, Centre National de la Recherche Scientifique, 31077 Toulouse, France; †Department of Cell and Molecular Biology, Uppsala University, Biomedical Center, SE-751 24 Uppsala, Sweden; ‡Institute of Chemical Sciences and Engineering, Ecole Polytechnique Fe´de´ rale de Lausanne, CH-1015 Lausanne, Switzerland; and §Centre for Infectious Disease, Institute of Cell and Molecular Science at Barts and The London, London E1 2AT, United Kingdom Edited by Christian R. H. Raetz, Duke University Medical Center, Durham, NC, and approved July 20, 2007 (received for review May 4, 2007) The Mycobacterium tuberculosis fatty acid synthase type II (FAS-II) metabolic pathway represents a valuable source for potential system has the unique property of producing unusually long-chain new pharmacological targets (2). fatty acids involved in the biosynthesis of mycolic acids, key molecules Isoniazid inhibits the elongation process leading to the for- of the tubercle bacillus. The enzyme(s) responsible for dehydration of mation of the main (meromycolic) chain of MAs. The four steps (3R)-hydroxyacyl-ACP during the elongation cycles of the mycobac- of the elongation cycles are monitored by an acyl carrier protein terial FAS-II remained unknown. This step is classically catalyzed by (ACP)-dependent FA synthase type II (FAS-II) system (5). -
Methylotroph Infections and Chronic Granulomatous Disease E
SYNOPSIS Methylotroph Infections and Chronic Granulomatous Disease E. Liana Falcone, Jennifer R. Petts, Mary Beth Fasano, Bradley Ford, William M. Nauseef, João Farela Neves, Maria João Simões, Millard L. Tierce IV, M. Teresa de la Morena, David E. Greenberg, Christa S. Zerbe, Adrian M. Zelazny, Steven M. Holland Chronic granulomatous disease (CGD) is a primary immu- polypeptide]) are inherited in an X-linked manner, whereas nodeficiency caused by a defect in production of phagocyte- defects in subunits p47phox (NCF1 [neutrophil cytosolic fac- derived reactive oxygen species, which leads to recurrent tor 1]), p22phox (CYBA [cytochrome b-245, α polypeptide]), infections with a characteristic group of pathogens not pre- p67phox (NCF2 [neutrophil cytosolic factor 2]), and p40phox viously known to include methylotrophs. Methylotrophs are (NCF4 [neutrophil cytosolic factor 4]) are inherited in an versatile environmental bacteria that can use single-carbon autosomal recessive manner (1,2). organic compounds as their sole source of energy; they rarely cause disease in immunocompetent persons. We CGD infections are often caused by a characteristic have identified 12 infections with methylotrophs (5 reported group of pathogens, including Staphylococcus aureus, here, 7 previously reported) in patients with CGD. Methy- Serratia marcescens, Burkholdheria cepacia complex, lotrophs identified were Granulibacter bethesdensis (9 Nocardia spp., and Aspergillus spp. (1). However, new cases), Acidomonas methanolica (2 cases), and Methylo- pathogens are emerging, and some reportedly are found bacterium lusitanum (1 case). Two patients in Europe died; almost exclusively in patients with CGD. Methylotrophs the other 10, from North and Central America, recovered are bacteria that can use single-carbon organic compounds after prolonged courses of antimicrobial drug therapy and, as their sole source of energy, the widespread availability for some, surgery. -
Short Reports Not Everything Acid Fast Is Mycobacterium Tuberculosis—A
J Clin Pathol 1998;51:535–536 535 Short reports J Clin Pathol: first published as 10.1136/jcp.51.7.535 on 1 July 1998. Downloaded from Not everything acid fast is Mycobacterium tuberculosis—a case report St Bartholomew’s Hospital, London EC1, UK: E S Olson, A J H Simpson, A J Norton, S S Das Department of Medical Microbiology E S Olson A J H Simpson S S Das Abstract pulmonary nocardiosis who was misdiag- Department of The Ziehl–Neelsen (ZN) stain is important nosed as having tuberculous empyema on Histopathology A J Norton in identifying organisms that are acid fast, pleural biopsy. principally Mycobacterium tuberculosis. (J Clin Pathol 1998;51:535–536) Correspondence to: However, decolorisation with a weaker DrSSDas, acid concentration (for example 1% hy- Keywords: Ziehl–Neelsen stain; acid fast organisms; St Bartholomew’s Hospital, Mycobacterium tuberculosis; Nocardia asteroides West Smithfield, London drochloric acid), often used in ZN staining EC1A 7BE, UK; email: in histology, can result in a wider variety [email protected] of organisms appearing acid fast and can Case report be a cause of misidentification. To illus- A 73 year old Hungarian woman with known Accepted for publication aortic valve disease was admitted to hospital 16 April 1998 trate this point, a patient is described with with symptoms and signs suggestive of increas- ing congestive cardiac failure and a superadded chest infection. Her white blood cell count (33 × 106/litre with 90% neutrophils) and erythro- cyte sedimentation rate (110 mm/hour) were very high and she also had anaemia (haemo- globin 8 g/dl) and mild renal impairment (blood urea 7.3 mmol/litre, creatinine 120 µmol/litre). -
A Life-Threatening Case of Disseminated Nocardiosis Due to Nocardia Brasiliensis
Case Report A life‑threatening case of disseminated nocardiosis due to Nocardia brasiliensis Elisabeth Paramythiotou, Evangelos Papadomichelakis, Georgia Vrioni1, Georgios Pappas2, Maria Pantelaki1, Fanourios Kontos1, Loukia Zerva1, Apostolos Armaganidis Nocardiosis is a rare disease caused by infection with Nocardia species, aerobic Access this article online actinomycetes with a worldwide distribution. A rare life‑threatening disseminated Nocardia Website: www.ijccm.org brasiliensis infection is described in an elderly, immunocompromised patient. Microorganism DOI: 10.4103/0972-5229.106512 was recovered from bronchial secretions and dermal lesions, and was identified using Quick Response Code: Abstract molecular assays. Prompt, timely diagnosis and appropriate treatment ensured a favorable outcome. Key words: Nocardia, Nocardia brasiliensis, nocardiosis Introduction steroids (64 mg) while no prophylaxis with trimethoprim‑ sulfamethoxazole was given. When he was first seen his Nocardiosis is a rare disease caused by infection with Nocardia species, aerobic actinomycetes with a worldwide was on tapered doses of methylprednisolone (20 mg) and distribution usually affecting immunocompromised oral cyclosporine. On physical examination the patient patients. The systems most commonly involved include was somnolent, his temperature was 38,5°C, blood the lung, the skin and the central nervous system. We pressure was 85/45 mmHg and pulse 120/min. Skin report a rare life‑threatening N. brasiliensis infection, the examination revealed the presence of intracutaneous first to be reported from Greece. nodular lesions (1.5 cm in diameter) on the forehead as well on both forearms [Figures 1a, b], with absence of Case Report regional lymphadenopathy. In chest examination crepts were present in both hemithoraces. His arterial blood A 67‑year–old Caucasian man was referred to the gases revealed significant hypoxemia (PO : 56 mmHg emergency department complaining for dyspnea and 2 in room air). -
Aerobic Gram-Positive Bacteria
Aerobic Gram-Positive Bacteria Abiotrophia defectiva Corynebacterium xerosisB Micrococcus lylaeB Staphylococcus warneri Aerococcus sanguinicolaB Dermabacter hominisB Pediococcus acidilactici Staphylococcus xylosusB Aerococcus urinaeB Dermacoccus nishinomiyaensisB Pediococcus pentosaceusB Streptococcus agalactiae Aerococcus viridans Enterococcus avium Rothia dentocariosaB Streptococcus anginosus Alloiococcus otitisB Enterococcus casseliflavus Rothia mucilaginosa Streptococcus canisB Arthrobacter cumminsiiB Enterococcus durans Rothia aeriaB Streptococcus equiB Brevibacterium caseiB Enterococcus faecalis Staphylococcus auricularisB Streptococcus constellatus Corynebacterium accolensB Enterococcus faecium Staphylococcus aureus Streptococcus dysgalactiaeB Corynebacterium afermentans groupB Enterococcus gallinarum Staphylococcus capitis Streptococcus dysgalactiae ssp dysgalactiaeV Corynebacterium amycolatumB Enterococcus hiraeB Staphylococcus capraeB Streptococcus dysgalactiae spp equisimilisV Corynebacterium aurimucosum groupB Enterococcus mundtiiB Staphylococcus carnosusB Streptococcus gallolyticus ssp gallolyticusV Corynebacterium bovisB Enterococcus raffinosusB Staphylococcus cohniiB Streptococcus gallolyticusB Corynebacterium coyleaeB Facklamia hominisB Staphylococcus cohnii ssp cohniiV Streptococcus gordoniiB Corynebacterium diphtheriaeB Gardnerella vaginalis Staphylococcus cohnii ssp urealyticusV Streptococcus infantarius ssp coli (Str.lutetiensis)V Corynebacterium freneyiB Gemella haemolysans Staphylococcus delphiniB Streptococcus infantarius -
Nocardia Bacteremia: a Single-Center Retrospective Review and A
International Journal of Infectious Diseases 92 (2020) 197–207 Contents lists available at ScienceDirect International Journal of Infectious Diseases journal homepage: www.elsevier.com/locate/ijid Nocardia bacteremia: A single-center retrospective review and a systematic review of the literature a,b, a,b,c a,b,c Eloise Williams *, Adam W. Jenney , Denis W. Spelman a Microbiology Unit, Alfred Health, 55 Commercial Rd, Melbourne, Victoria, Australia b Department of Infectious Diseases, Alfred Health, 55 Commercial Rd, Melbourne, Victoria, Australia c Department of Infectious Diseases, Monash University, Melbourne, Victoria, Australia A R T I C L E I N F O A B S T R A C T Article history: Objectives: Nocardia bacteremia is a rare but severe disease associated with high mortality. This Received 14 August 2019 systematic review is the largest and most comprehensive review performed over the past 20 years. Received in revised form 21 December 2019 Methods: A single-center retrospective review of Nocardia bacteremia was performed using hospital Accepted 13 January 2020 microbiology records from January 1, 2010 to December 31, 2017. A systematic literature review was also performed to identify cases of Nocardia bacteremia described in the NCBI PubMed database in English Keywords: between January 1, 1999 and December 31, 2018. Nocardia Results: Four new cases of Nocardia bacteremia are described. The systematic review identified 134 cases Nocardiosis with sufficient information available for analysis. Of the total 138 cases, the median age was 58 years Bacteremia (interquartile range (IQR) 44–69 years) and 70% were male. Eighty-one percent were immunocom- Central line-associated bloodstream infection promised (corticosteroid use (49%), hematological malignancy (20%), solid organ transplant (20%), Immunocompromise solid organ malignancy (19%), and hematopoietic stem cell transplantation (15%)) and 29% had endovascular devices.